Navigation Links
Sex differences in the normal composition of the heart may explain unique gender outcomes
Date:3/15/2013

Groundbreaking new insights on the differences in cardiovascular pathophysiology between women and men will be presented by Marianne Legato, MD, a globally recognized expert in gender specific medicine, and consultant to the Women's Heart Foundation in her keynote address at the 98th Annual American Medical Women's Association (AMWA) Conference in New York City, on March 15-17, 2013.

"I will introduce unique nervous systems differences in cardiac function between women and men, and present findings that support variations in the normal composition of the heart with regard to cardiac outcomes," says Dr. Legato, clinical professor emeritus of medicine at Columbia University College of Physicians and Surgeons.

Dr. Legato calls for accelerating research to evaluate the biological differences in heart health for both sexes to gain insights into preventive care and delivery of the best possible outcomes when coronary artery disease develops.

Other topics that will be addressed during the AMWA conference range from mentoring and breaking the glass ceiling to issues in global women's health such as advances in vascular surgery, sex differnces in cardiovascular disease, inflammatory skin disorders, arthritis, bleeding disorders and oncology


'/>"/>

Contact: Jodi Godfrey
jgodfrey@gmail.com
973-809-5462
Sex and Gender Women's Health Collaborative
Source:Eurekalert

Page: 1

Related biology news :

1. Autism risk gene linked to differences in brain structure
2. Knee injuries in women linked to motion, nervous system differences
3. Biologists turn back the clock to understand evolution of sex differences
4. Scientists find differences in naked mole rats protein disposers
5. Differences between human twins at birth highlight importance of intrauterine environment
6. Differences in the genomes of related plant pathogens
7. Artificial intelligence helps detect subtle differences in mutant worms
8. Studying sex differences in autism focus of $15 million NIH award to Yale center
9. Researcher finds gender differences in seasonal auditory changes
10. Single gene might explain dramatic differences among people with schizophrenia
11. Genetic abnormality offers diagnostic hope for childrens cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 15, 2014 Research and Markets ... addition of the "Samsung Galaxy S5 - ... report to their offering. ... totally different sensing technology than the iPhone 5S, ... sensor in its product. The Galaxy ...
(Date:12/17/2014)... YORK , Dec. 15, 2014  HITLAB ... Good Clinical Practices (GCP) audit to confirm its ... (FDA) regulations. This accomplishment enables HITLAB to conduct ... utilizing the highest principles for patient safety and ... improve global healthcare access, quality, and delivery with ...
(Date:12/17/2014)... , Dec. 16, 2014 Research and ... the addition of the "Global Chemical Sensor ... http://photos.prnewswire.com/prnh/20130307/600769 ... the increasing demand for medical sensors in biomedical ... data for quick and correct diagnosis during surgical ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
... Change: Required Reductions of Carbon Emissions to Protect Young ... colleagues, and announces call for papers on responses to ... impacts of global warming using ongoing observations and paleoclimate ... representations of the global carbon cycle and temperature to ...
... EVENT: The second annual Epigenetic Control and ... and chromatin remodeling contribute to various processes that lead ... Friday, Dec. 12-13, at the At the Beckman Center ... Irvine, Calif. INFORMATION: Media planning to ...
... to sustaining life on Earth, is proving deadly for young peregrine ... in Oecologia has found that an increase in the ... posing a threat not seen in this species since before pesticides ... , The study is among the first to directly link rainfall ...
Cached Biology News:Assessing dangerous climate change and call for climate change response papers 2Top scientists to present at Epigenetic Control and Cellular Plasticity symposium 2Rainfall to blame for decline in Arctic peregrines 2
(Date:12/19/2014)... NEW YORK , Dec. 18, 2014 ... novel therapies for the treatment of chronic pain, announced ... held today. "This was a transformational year ... a promising future for our company," said Sergio ... past year, we have executed on key financial, human ...
(Date:12/17/2014)... December 17, 2014 Ipsen Biopharmaceuticals, ... IPN; ADR: IPSEY), today announced that ... as Somatuline®) was approved by the U.S. Food ... gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult patients with ... metastatic disease to improve progression-free survival (PFS). , ...
(Date:12/17/2014)... Audacity, a leading California-based health and ... the Huntsworth Health Group, is proud to announce the ... her role, Gonzales will serve as Senior Vice President ... to welcome a talent of Jamie’s caliber to the ... “She is a proven healthcare innovation leader and brand ...
(Date:12/17/2014)... Mass. , Dec. 17, 2014   Synageva ... biopharmaceutical company developing therapeutic products for rare disorders, announced ... Conference being held in San Francisco, CA. ... President and Chief Executive Officer, will present on Monday, ... EST).  The presentation will be webcast live and may ...
Breaking Biology Technology:Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2
... high-tech networking event starting in Appleton, Wisconsin. The ... investors and others who live in the Fox ... Tobey Andropolis and Bob Pankratz insist that this ... enterprise. Instead, the Hive is devoted to helping ...
... 2004 in Lille, France. This four-year-old conference draws ... transformative power of technology. As the lead speaker on ... and Social Conditions, I was eager, frankly, to dispense ... to hear from and debate my fellow panelists. , ...
... scientists have research on the brain. In the past few ... effort into projects that can combat neural disorders and help ... area of human testing and getting closer to market, their ... Implants encourage mind over movement ,One major effort at ...
Cached Biology Technology:A new high-tech networking event buzzes in Appleton 2A new high-tech networking event buzzes in Appleton 3Achieving digital solidarity 2Achieving digital solidarity 3Achieving digital solidarity 4Mental research at UW-Madison could correct disabilities 2Mental research at UW-Madison could correct disabilities 3
[5,6,8,9,12,14,15(n)-3H]Prostaglandin D2, 925 kBq, 25 uCi. Methanol:water:acetonitrile (3:2:1) solution.> 3.0 TBq/mmol, > 80 Ci/mmol.3.7 MBq/ml, 100 uCi/ml. Category: Radiochemicals &Radiation Safety...
...
One-step, microplate or cuvet, turbidometric, linear detection range 0.096 mg/dL to 11.5 mg/dL. Procedure: 5 min....
One-step, microplate or cuvet, colorimetric, detection range 0.1 mg/dL to 3 mg/dL. Procedure: 10 min....
Biology Products: